Long-term survival and quality of life in patients treated with a national ALL treatment protocol 15-20 years earlier: IDM/HDM and late effects? - Moe,PJ.; Holen,A.; Glomstein,A.; Madsen,B.; Hellebostad,M.; Stokland,T.; Wefring,KW.; Steen-Johnsen,J.; Nielsen,B.; Howlid,H.; Borsting,S.; Hapnes,C. (Pediatr Hematol Oncol, 1997)